Elevance Health is a healthcare plan company located in Indiana, United States, which is part of the Healthcare sector, and is traded under the ticker ELV on the NYSE exchange.
Elevance Health stock last closed at $429.65, up 2.73% from the previous day, and has increased 41.43% in one year. It has overperformed other stocks in the Healthcare Plans industry by 0 percentage points. Elevance Health stock is currently +56.33% from its 52-week low of $274.84, and -4.67% from its 52-week high of $450.69.
There are currently 216.87M shares of ELV outstanding. The market cap of ELV is $93.18B. In the past 24 hours, 906,000 ELV shares were traded.
You will need a brokerage account in order to access the NYSE market and buy ELV stock.
Based on our analysis, eToro is the best brokerage. Here's why:
Get $10 towards your purchase of shares by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've chosen the right brokerage, the next step is to fill out some personal details so you are able to buy ELV stock today.
Now that you have created your account on one of the best stock apps, you need to deposit funds:
Watch the tutorial below to see the process of transferring funds into your investment account.
After you have identified the best place to buy Elevance Health stock, it's crucial to research their stock prior to investing, so you actually understand the risk as well as the opportunity.
WallStreetZen was created to help part-time investors do better fundamental analysis quickly.
You can see all of the due diligence checks on ELV's stock page.
You can use a variety of different financial metrics, analyses, models, and charts to gauge ELV's intrinsic value.
Using relative valuations metrics:
You can access more valuation research on ELV's stock here.
Out of 16 Wall Street analysts who monitor ELV, the consensus analyst rating on ELV is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they financial advice.
Ben Hendrix, a top 5% analyst from RBC Capital maintains ELV with a hold rating and raises their ELV price target from $424.00 to $455.00, on Oct 22, 2026.
Andrew Mok, a top 19% analyst from Barclays maintains ELV with a strong buy rating and raises their ELV price target from $469.00 to $472.00, on Oct 22, 2026.
Barclays's Andrew Mok raised their price target on Elevance Health (NYSE: ELV) by 0.6% from $469 to $472 on 2026/10/22. The analyst maintained their Strong Buy rating on the stock.
Elevance Health reported its Q3 2026 earnings.
Raising their price target, Mok said they adjusted their estimates after assessing the results.
For Q3 2026, Elevance Health reported:
For FY 2026, management guided:
President & CEO Gail K. Boudreaux commented: "Elevance Health's third quarter results reflect stronger execution across our diversified portfolio and underscore the earnings power of the business.
"We are raising our 2026 earnings outlook and remain confident in delivering at least 12% growth in adjusted diluted earnings per share in 2027 from our higher earnings baseline of at least $26.75/
"By bringing together the capabilities of our Health Benefits business and Carelon, we are improving the healthcare experience, strengthening our competitive advantage, and creating long-term value for our shareholders."
Michael Ha, a bottom 6% analyst from Baird maintains ELV with a hold rating and raises their ELV price target from $393.00 to $406.00, on Oct 22, 2026.
Lance Wilkes, a top 19% analyst from Bernstein maintains ELV with a buy rating and raises their ELV price target from $482.00 to $488.00, on Jul 17, 2026.
Whit Mayo, a top 18% analyst from Leerink Partners maintains ELV with a hold rating and raises their ELV price target from $364.00 to $395.00, on Jul 17, 2026.
You can dive deeper into what analysts are saying on the Elevance Health stock forecast page.
Last year, ELV earnings were $4.96B. During the past five year, ELV's earnings have gone up by 5.55% per year. This was slower than the Healthcare Plans industry average of 7.61%.
Last year, ELV revenue was $201.11B. Over the last five year, ELV's revenue has increased by 9.25% per year. This was slower than the Healthcare Plans industry average of 10.85%.
Dig into ELV's earnings and revenue performance here.
In the last 12 months, insiders at ELV have sold more shares than they have bought.
Ratnakar Lavu, EVP;CXO of ELV, was the latest ELV insider to sell. They sold $572,000.00 worth of ELV shares on Nov 5, 2026.
Get more info about who owns ELV shares here.
Elevance Health pays a dividend of 1.6%, compared to the Healthcare Plans industry's average dividend yield of 1.94%. If you owned $1,000 worth of ELV stock, you would have received $15.99 in the past 12 months.
Elevance Health dividend payments have consistently grown over the past decade and have remained stable.
Find more analysis about Elevance Health dividend yield and history here.
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
You have two main order types:
Click the Open button and your broker will execute the order.
If you need more info about buying stocks on eToro, click the helpful video below:
Now that you own some shares in ELV, you'll want to keep up with your new company.
Make a watchlist to get alerted to the latest events about your ELV stock.
To reiterate, here are the 6 steps to buy stock in Elevance Health:
If you require a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get the latest scoop on your investment in Elevance Health, create your watchlist below.